NASDAQ:DERM Journey Medical Q3 2026 Earnings Date & Estimates $4.97 -0.16 (-3.12%) Closing price 04:00 PM EasternExtended Trading$4.96 0.00 (-0.10%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Journey Medical is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 11, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Journey Medical in Q3 2026Journey Medical is expected to post earnings of $0.02 per share on revenue of $21.90 million. In the same quarter a year earlier Journey Medical reported -$0.09 per share on revenue of $17.63 million. Journey Medical last reported on August 12, 2026, posting -$0.01 per share and beating the -$0.0225 consensus estimate. Journey Medical has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.02Expected Revenue$21.90 millionPrior-Year EPS-$0.09Prior-Year Revenue$17.63 millionExpected Revenue Growth+24.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.01 (Beat by +$0.0125)Last Quarter Revenue$18.51 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Journey Medical Q3 2026 Earnings FAQ When does Journey Medical report Q3 2026 earnings? Journey Medical (NASDAQ:DERM) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Journey Medical's Q3 2026 earnings call? Journey Medical's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Journey Medical? Analysts expect Journey Medical to post earnings of $0.02 per share for Q3 2026. How much revenue is Journey Medical expected to report? The consensus revenue estimate for Journey Medical is $21.90 million for Q3 2026. Journey Medical Earnings HeadlinesReviewing Journey Medical (NASDAQ:DERM) and Vireo Growth (OTCMKTS:VREOD)October 8, 2026 | americanbankingnews.comCritical Survey: Journey Medical (NASDAQ:DERM) versus Synaptogenix (NASDAQ:TAOX)October 7, 2026 | americanbankingnews.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 16 at 1:00 AM | Weiss Ratings (Ad)Are options traders betting on a big move in Journey Medical stock?September 21, 2026 | msn.comJourney Medical: A Small Pharma With A Large Growth OpportunitySeptember 19, 2026 | seekingalpha.comJourney Medical Corporation to Participate in September 2026 Investor ConferencesSeptember 8, 2026 | globenewswire.comSee More Journey Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Journey Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Journey Medical and other key companies, straight to your email. Email Address About Journey MedicalJourney Medical (NASDAQ:DERM) (NASDAQ: DERM) is a commercial-stage pharmaceutical company focused on developing, acquiring and commercializing prescription therapies for medical dermatology. The company’s portfolio is intended to address conditions treated by dermatologists, including hyperhidrosis, acne, fungal skin infections and inflammatory skin disorders. Journey Medical’s marketed products include Qbrexza (glycopyrronium tosylate) cloth for primary axillary hyperhidrosis, Targadox (doxycycline hyclate) capsules for moderate-to-severe inflammatory lesions associated with acne vulgaris, and Exelderm (sulconazole nitrate) cream and solution for certain fungal skin infections. Its portfolio also includes Luxiq (betamethasone valerate) foam, a topical corticosteroid used for responsive dermatoses of the scalp. Founded in 2014, Journey Medical is headquartered in Scottsdale, Arizona, and primarily serves the United States dermatology market through its commercial and sales operations. Claude Maraoui, a co-founder of the company, serves as its chief executive officer.View Journey Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
